Euroopan unioni - suomi - EMA (European Medicines Agency)

janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastiset aineet - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Suomi - suomi - Fimea (Suomen lääkevirasto)

stada arzneimittel ag - terbinafine hydrochloride - emulsiovoide - 10 mg/g - terbinafiini